Cytopenias + mutations - dysplasia = what?

Affiliations

Free article

Comment

David P Steensma. Blood. 2015.

Free article

. 2015 Nov 19;126(21):2349-51.

doi: 10.1182/blood-2015-10-672659.

No abstract available

Comment on

Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.
Cargo CA, Rowbotham N, Evans PA, Barrans SL, Bowen DT, Crouch S, Jack AS. Cargo CA, et al. Blood. 2015 Nov 19;126(21):2362-5. doi: 10.1182/blood-2015-08-663237. Epub 2015 Sep 21. Blood. 2015. PMID: 26392596
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
Kwok B, Hall JM, Witte JS, Xu Y, Reddy P, Lin K, Flamholz R, Dabbas B, Yung A, Al-Hafidh J, Balmert E, Vaupel C, El Hader C, McGinniss MJ, Nahas SA, Kines J, Bejar R. Kwok B, et al. Blood. 2015 Nov 19;126(21):2355-61. doi: 10.1182/blood-2015-08-667063. Epub 2015 Oct 1. Blood. 2015. PMID: 26429975 Free PMC article.